POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) PROMOTES THE RELEASE OF HMGB1 INCREASING INTESTINAL INFLAMMATION

被引：0
|
作者：
Mancuso, Anna Barbara
Vitali, Roberta
Palone, Francesca
Fiaschini, Noemi
Colantoni, Eleonora
Cucchiara, Salvatore
Isoldi, Sara
Rossetti, Danilo
Stronati, Laura
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
268
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [41] Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis
    El-Hamoly, Tarek
    Hajnady, Zoltan
    Nagy-Penzes, Mate
    Bakondi, Edina
    Regdon, Zsolt
    Demeny, Mate A.
    Kovacs, Katalin
    Hegedus, Csaba
    Abd El-Rahman, Sahar S.
    Szabo, Eva
    Maleth, Jozsef
    Hegyi, Peter
    Virag, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [42] Targeting BRCA1 Localization to Augment Tumor Cell Susceptibility to Poly (ADP-ribose) Polymerase-1 (PARP1) Inhibition
    Yang, S.
    Nowsheen, S.
    Xia, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S89 - S89
  • [43] The 3′-5′ Exonuclease, TREX1, Interacts with Poly(ADP-ribose) Polymerase-1 (PARP1) in Response to DNA Damage
    Miyazaki, Takuya
    Kim, Yong-Soo
    Yoon, Jeong-Heon
    Wang, Hongsheng
    Morse, Herbert C., III
    BLOOD, 2012, 120 (21)
  • [44] Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
    Shin, Hyeon-Jun
    Kwon, Hyuk-Kwon
    Lee, Jae-Hyeok
    Gui, Xiangai
    Achek, Asma
    Kim, Jae-Ho
    Choi, Sangdun
    SCIENTIFIC REPORTS, 2015, 5
  • [45] PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids
    Vitali, Roberta
    Mancuso, Anna Barbara
    Palone, Francesca
    Pioli, Claudio
    Cesi, Vincenzo
    Negroni, Anna
    Cucchiara, Salvatore
    Oliva, Salvatore
    Carissimi, Claudia
    Laudadio, Ilaria
    Stronati, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [46] Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
    Csonka, Tamas
    Murnyak, Balaks
    Szepesi, Rita
    Kurucz, Andrea
    Klekner, Almos
    Hortobagyi, Tibor
    FOLIA NEUROPATHOLOGICA, 2014, 52 (02) : 111 - 120
  • [47] Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
    Hyeon-Jun Shin
    Hyuk-Kwon Kwon
    Jae-Hyeok Lee
    Xiangai Gui
    Asma Achek
    Jae-Ho Kim
    Sangdun Choi
    Scientific Reports, 5
  • [48] The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity
    Zhai, Lili
    Li, Shuai
    Li, Xiaoyan
    Li, Huilan
    Gu, Feng
    Guo, Xiaojing
    Liu, Fangfang
    Zhahg, Xinmin
    Fu, Li
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (02) : 130 - 137
  • [49] Poly (ADP-ribose) polymerase-1 (PARP1) inhibitor BSI-201 in combination with temozolomide (TMZ) in malignant glioma
    Blakeley, J. O.
    Ye, X.
    Grossman, S. A.
    Mikkelsen, T.
    Rosenfeld, M. R.
    Bradley, C. R.
    Eichler, A. F.
    Nabors, L. B.
    Desideri, S.
    Supko, J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities
    Rajawat, Jyotika
    Shukla, Nidhi
    Mishra, Durga Prasad
    MEDICINAL RESEARCH REVIEWS, 2017, 37 (06) : 1461 - 1491
12345